InvestorsHub Logo
Followers 91
Posts 5592
Boards Moderated 0
Alias Born 06/05/2008

Re: Rymankoly post# 6681

Monday, 08/28/2017 12:08:44 PM

Monday, August 28, 2017 12:08:44 PM

Post# of 8169
Sure I can compare them,

And you can contrast them too.

The point is that once a micropharma proves itself in a high liquidity low interest rate environment, it WILL BE acquired and CLRB will laugh all the way to the bank...no matter what common stock share holders think.

https://www.thestreet.com/story/14201217/1/global-blood-shares-pop-on-priority-designation-kite-pharma-rises-on-patent-news-biotech-movers.html


Gee wizz CLRB IS AT $1.74 already...swoon time?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CLRB News